Your browser doesn't support javascript.
loading
Hepatitis B core-related antigen levels predict pegylated interferon-α therapy response in HBeAg-positive chronic hepatitis B.
Beudeker, Boris Jb; Groothuismink, Zwier Ma; de Man, Robert A; Janssen, Harry LA; van der Eijk, Annemiek A; Boonstra, Andre; Sonneveld, Milan J.
Afiliação
  • Beudeker BJ; Department of Gastroenterology & Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Groothuismink ZM; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • de Man RA; Department of Gastroenterology & Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Janssen H; Department of Gastroenterology & Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • van der Eijk AA; Department of Gastroenterology & Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Boonstra A; Toronto Center for Liver Disease, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • Sonneveld MJ; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
Antivir Ther ; 25(4): 217-222, 2020.
Article em En | MEDLINE | ID: mdl-32744512

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Antígenos E da Hepatite B Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Antígenos E da Hepatite B Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article